Bioactivity:

CCB02 is a selective CPAP-tubulin interaction inhibitor (IC50: 689 nM) with anti-tumor activity. CCB02 shows no inhibition on the cell cycle- and centrosome-related kinases, or the phosphorylation status of Aurora-A, CDK2, Plk1, Plk2, and CHK1.

CAS nr:

2100864-57-9

Purity:

98%

Molecular Weight:

235,24

SMILES:

N#CC1=C(OC)N=CC2=CC3=CC=CC=C3N=C12

Formula:

C14H9N3O

Pathway:

Others

Target:

Others